Skip to main content

Site notifications

THALOMID thalidomide 100 mg hard capsule blister pack, Celgene Pty Ltd , CON-1045

Product name
THALOMID thalidomide 100 mg hard capsule blister pack
Sponsor name
Celgene Pty Ltd
Consent start
Consent no.
CON-1045
Duration
The consent is effective from 7 December 2022 until 28 November 2024.
Standard
Paragraph 8(1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product(s) labels refer to the previous registered address of the sponsor.
Conditions imposed
1. The labels to which this consent applies are those previously approved with the previous sponsor address.
Import, Supply, &/or Export
supply
Therapeutic product type
Prescription medicines